Events

Update: We have been officially announced as a Falling Walls winner!


Singapore Startup Proteona selected as a Falling Walls Breakthrough of the Year Finalist, Science Start-Up

Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology

Proteona is proud to be selected as a Science Start-Up Breakthrough of the Year finalist by Falling Walls Remote 2020. This year, the Falling Walls committee received than 900 nominees from 111 countries for all categories. For Science Start-up category, 10 winners will be selected based on their scientific and social impact.

You can watch a five minutes video presentation by Proteona CEO, Dr Andreas Schmidt, on the Falling Walls event website.

The winners will be anounced on Friday, 6 Nov 2020, with live presentations at 14.15-15.15 CET (21.15-22.15 SGT).

Join us from 1-10 November to catch our video presentation and to attend the exciting line up of events.

Follow us on LinkedIn to stay updated!

Our LinkedIn Page


The Falling Walls Conference is a world science summit that highlights the latest scientific and social breakthroughs. It first took place on November 9th, 2009, 20 years since the fall of the Berlin Wall. Since then, it features the top innovations in all fields of science around the world, showcasing how innovation can make a positive impact. We are excited to see you there!

Register for Falling Walls Remote 2020

Check out the past Falling Walls Venture finalists

Meet the distinguished panel of juries for “Falling Walls Start-Up of the year” 2020



For media queries, please contact:

Dr Andreas Schmidt
Proteona
Email: info@proteona.com

About Proteona

Proteona is a precision medicine company in Singapore, Germany, and the US that is pioneering the use of single cell multi-omics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona enables pharmaceutical companies, biotech partners, and clinicians to integrate single cell level precision into their clinical projects. Proteona continues to develop comprehensive, disease-specific single cell databases combining gene expression, protein expression, and mutation information derived from each individual cells as well as drug response data for each sample. Proteona has been selected as a “One to Watch” by Nature Research Spinoff Award and a Winner of Falling Walls Ventures Breakthrough of the Year 2020. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR).

https://proteona.com/